Huynh Mai Anh, Spektor Alexander
Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ann Palliat Med. 2019 Jul;8(3):326-336. doi: 10.21037/apm.2019.07.08.
Radiation therapy is commonly used in the metastatic setting to palliate pain, neurological deficits, bleeding and other complications of metastatic disease, allowing patients to live longer and have better quality of life. Despite the effective use of radiation and other palliative treatment modalities, many patients continue to experience poorly controlled pain and other serious sequelae of their disease, underscoring the need for additional research in this area. In this review we highlight recent developments impacting the fields of palliative care and radiation oncology and describe opportunities for research and innovation including studies of tumor microenvironment, identification of effective biomarkers of tumor response and combinatorial treatments with new systemic agents. It is our hope that progress in these fields will improve the lives of patients living with advanced malignancies.
放射治疗常用于转移性疾病的治疗,以缓解疼痛、神经功能缺损、出血及转移性疾病的其他并发症,使患者活得更长且生活质量更高。尽管放射治疗及其他姑息治疗方式得到了有效应用,但许多患者仍经历着控制不佳的疼痛及疾病的其他严重后遗症,这凸显了该领域进一步研究的必要性。在本综述中,我们重点介绍了影响姑息治疗和放射肿瘤学领域的最新进展,并描述了研究与创新的机会,包括肿瘤微环境研究、肿瘤反应有效生物标志物的鉴定以及与新型全身药物的联合治疗。我们希望这些领域的进展将改善晚期恶性肿瘤患者的生活。